Exelixis (NASDAQ:EXEL – Get Rating) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Thursday. EXEL has been the topic of several other research reports. EF Hutton Acquisition Co. I reissued a “buy” rating and set a $24.00 target price on shares of […]

Related Keywords

Jeffrey Hessekiel , Alanm Garber , Farallon Capital Management , Securities Exchange Commission , Ef Hutton Acquisition Co , Blackrock Inc , Vanguard Group Inc , Exelixis Inc , Exelixis Company Profile , Credit Suisse Group , Get Rating , Suisse Group , Director Alan , Exchange Commission , Street Corp , Capital Management , Stelios Papadopoulos , Exelixis Daily , Exelixis , Nasdaq Exel , Rexel , Medical , 30161q10 , Downgrade , Stocknews Com ,